Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Research Coverage on Small and Micro-Cap Companies

Equity Bottom-Up

<ul><li>On May 14, 2025, FibroBiologics, Inc. (FBLG) announced financial results for the first quarter of 2025 and provided a business update.</li><li>The company recently delivered a poster presentation highlighting preclinical results showing the potential for a fibroblast-based therapy in the treatment of psoriasis.</li><li>The results showed fibroblast-based spheroids had therapeutic efficacy in both acute and chronic mouse models of psoriasis.</li></ul>

On May 14, 2025, FibroBiologics, Inc. (FBLG) announced financial results for the first quarter of 2025 and provided a business update.The company recently delivered a poster presentation highlighting preclinical results showing the potential for a fibroblast-based therapy in the treatment of psoriasis.The results showed fibroblast-based spheroids had therapeutic efficacy in both acute and chronic mouse models of psoriasis.

FBLG: Poster Presentation Shows Potential for Fibroblast Therapy in Psoriasis 